1. Home
  2. TYRA vs UTI Comparison

TYRA vs UTI Comparison

Compare TYRA & UTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

N/A

Current Price

$20.07

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo Universal Technical Institute Inc

UTI

Universal Technical Institute Inc

N/A

Current Price

$20.63

Market Cap

1.1B

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
TYRA
UTI
Founded
2018
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2021
2003

Fundamental Metrics

Financial Performance
Metric
TYRA
UTI
Price
$20.07
$20.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
6
Target Price
★ $47.45
$38.83
AVG Volume (30 Days)
957.1K
★ 1.7M
Earning Date
11-04-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 50.67
EPS
N/A
★ 0.28
Revenue
N/A
★ $835,616,000.00
Revenue This Year
N/A
$7.25
Revenue Next Year
N/A
$8.44
P/E Ratio
★ N/A
$72.54
Revenue Growth
N/A
★ 14.05
52 Week Low
$13.35
$18.02
52 Week High
$40.65
$51.34

Technical Indicators

Market Signals
Indicator
TYRA
UTI
Relative Strength Index (RSI) 35.51 46.72
Support Level $18.66 $19.52
Resistance Level $27.00 $21.70
Average True Range (ATR) 1.12 0.89
MACD -0.14 0.44
Stochastic Oscillator 7.94 78.51

Price Performance

Historical Comparison
TYRA
UTI

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About UTI Universal Technical Institute Inc

Universal Technical Institute Inc is an educational institution. It provides undergraduate degree, as well as certificate programs for technicians in the automotive, diesel, collision repair, motorcycle and marine fields. The company's reportable segment which includes Universal Technical Institute (UTI) and Concorde Career Colleges, Corporate. Majority of the revenue is generated from UTI segment which provides different kinds of degree and non-degree transportation and skilled trades technical training programs under brands such as Universal Technical Institute, Motorcycle Mechanics Institute, Marine Mechanics Institute and others. It also provides dealer technician training or instructor staffing services to manufacturers.

Share on Social Networks: